News
23h
Asianet Newsable on MSNHims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent ExpiresThe telehealth company stated that its entry to Canada will come as generic Semaglutide hits the market for the first time.
Ozempic in particular led Jeremy Clarkson to have some pretty horrible sickness, while others have noticed changes in their muscle strength, face structure and even in their downstairs area after ...
For Immediate Release Chicago, IL – July 10, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog.
The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.
14h
Verywell Health on MSNWhat Happens to Your Hair When You Take Weight-Loss Medications?Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
Whether identifying as Republicans or Democrats, about 70% of adults surveyed say health insurers exert too much influence ...
There in my bedroom, in the middle of the night, I saw my 11-year-old daughter clutching her ribs in agony. In the mad dash to hospital, I tried to stay calm, but I was full of fear and ...
The side effects of eating more than the small amount would lead him to become so bloated that he would burp twice every three minutes for hours, and they would smell like sulphur.
Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required ...
18h
CT Insider on MSNDan Haar: Ozempic and Wegovy are expensive. Connecticut wants to make its own cheaper version.If there's one thing blue-state liberals and Trump populists can agree on, it's that pharmaceutical firms charge too much for their drugs. That core belief has propelled Connecticut to the leading ...
Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results